Works matching IS 13524585 AND DT 2017 AND VI 23 AND IP 10
Results: 19
Dilemmas in medical ethics in the age of big data.
- Published in:
- Multiple Sclerosis Journal, 2017, v. 23, n. 10, p. 1306, doi. 10.1177/1352458517722056
- By:
- Publication type:
- Article
Clinical commentary on ‘Recurrent natalizumab-related aseptic meningitis in a patient with multiple sclerosis’, by Foley et al.
- Published in:
- Multiple Sclerosis Journal, 2017, v. 23, n. 10, p. 1427, doi. 10.1177/1352458517712868
- By:
- Publication type:
- Article
Stop inflammation and you stop neurodegeneration in MS – Commentary.
- Published in:
- Multiple Sclerosis Journal, 2017, v. 23, n. 10, p. 1323, doi. 10.1177/1352458517707587
- By:
- Publication type:
- Article
Stop inflammation and you stop neurodegeneration in MS – NO.
- Published in:
- Multiple Sclerosis Journal, 2017, v. 23, n. 10, p. 1321, doi. 10.1177/1352458517707267
- By:
- Publication type:
- Article
Stop inflammation and you stop neurodegeneration in MS – YES.
- Published in:
- Multiple Sclerosis Journal, 2017, v. 23, n. 10, p. 1320, doi. 10.1177/1352458517707266
- By:
- Publication type:
- Article
A new role for evoked potentials in MS? Repurposing evoked potentials as biomarkers for clinical trials in MS.
- Published in:
- Multiple Sclerosis Journal, 2017, v. 23, n. 10, p. 1309, doi. 10.1177/1352458517707265
- By:
- Publication type:
- Article
The use of clinical databases in disease outcomes research: Is the ethics of IRB review keeping up?
- Published in:
- Multiple Sclerosis Journal, 2017, v. 23, n. 10, p. 1325, doi. 10.1177/1352458517707264
- By:
- Publication type:
- Article
Recurrent natalizumab-related aseptic meningitis in a patient with multiple sclerosis.
- Published in:
- 2017
- By:
- Publication type:
- Case Study
Closing the gap on employment rates: Success stories pave the way for policy works-in-progress.
- Published in:
- 2017
- By:
- Publication type:
- Letter to the Editor
Impairment of social cognition in multiple sclerosis: Amygdala atrophy is the main predictor.
- Published in:
- Multiple Sclerosis Journal, 2017, v. 23, n. 10, p. 1358, doi. 10.1177/1352458516680750
- By:
- Publication type:
- Article
Identification and validation of clinically meaningful benchmarks in the 12-item Multiple Sclerosis Walking Scale.
- Published in:
- Multiple Sclerosis Journal, 2017, v. 23, n. 10, p. 1405, doi. 10.1177/1352458516680749
- By:
- Publication type:
- Article
Quantifying risk of early relapse in patients with first demyelinating events: Prediction in clinical practice.
- Published in:
- Multiple Sclerosis Journal, 2017, v. 23, n. 10, p. 1346, doi. 10.1177/1352458516679893
- By:
- Publication type:
- Article
Differential effects of aging on motor and cognitive functioning in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2017, v. 23, n. 10, p. 1385, doi. 10.1177/1352458516679036
- By:
- Publication type:
- Article
Closing the gap: Longitudinal changes in employment for Australians with multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2017, v. 23, n. 10, p. 1415, doi. 10.1177/1352458516678934
- By:
- Publication type:
- Article
Effectiveness of mycophenolate mofetil as first-line therapy in AQP4-IgG, MOG-IgG, and seronegative neuromyelitis optica spectrum disorders.
- Published in:
- Multiple Sclerosis Journal, 2017, v. 23, n. 10, p. 1377, doi. 10.1177/1352458516678474
- By:
- Publication type:
- Article
Leptomeningeal contrast enhancement is associated with progression of cortical atrophy in MS: A retrospective, pilot, observational longitudinal study.
- Published in:
- Multiple Sclerosis Journal, 2017, v. 23, n. 10, p. 1336, doi. 10.1177/1352458516678083
- By:
- Publication type:
- Article
Waterpipe smoking associated with multiple sclerosis: A population-based incident case–control study.
- Published in:
- Multiple Sclerosis Journal, 2017, v. 23, n. 10, p. 1328, doi. 10.1177/1352458516677867
- By:
- Publication type:
- Article
CoDuSe group exercise programme improves balance and reduces falls in people with multiple sclerosis: A multi-centre, randomized, controlled pilot study.
- Published in:
- Multiple Sclerosis Journal, 2017, v. 23, n. 10, p. 1394, doi. 10.1177/1352458516677591
- By:
- Publication type:
- Article
Alemtuzumab improves quality-of-life outcomes compared with subcutaneous interferon beta-1a in patients with active relapsing-remitting multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2017, v. 23, n. 10, p. 1367, doi. 10.1177/1352458516677589
- By:
- Publication type:
- Article